EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitSystematische ÜbersichtOpen access · CC BY-NC 3.0

Interleukin-Mediated Macrophage Polarization in Allergic Rhinitis Inflammation: A Systematic Review

Haihuan Luan, Shouwei Gao, Yuanyuan Ma, Zeyu Yu, Xiaonan Li

Journal of Inflammation Research · 2026-07 · Volume 19 · 1-19

DOI: 10.2147/jir.s607167 ↗

At a glance

Übersichtsarbeit in Journal of Inflammation Research, 2026-07. Written by Haihuan Luan and 4 co-authors. Institution: Department of Stomatology, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, 150040, People's Repub…. Cited 3 times so far (Crossref). The full text is freely available (open access, CC BY-NC 3.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

Allergic rhinitis (AR) is driven by interleukin (IL) network dysregulation and imbalanced macrophage polarization. This systematic review summarizes the molecular mechanisms by which ILs regulate macrophage phenotypic switching in AR inflammation.

Methods

We screened the PubMed and Embase databases from January 2010 to January 2026 to identify published studies. The search keywords used were as follows: ["interleukin" or "IL"], ["allergic rhinitis" or "AR"], ["macrophages"] and ["inflammation"]. A total of 223 peer-reviewed studies on human/animal models were included, and articles that did not meet the requirements were excluded.

Results

Pro-inflammatory ILs (IL-4/IL-13, IL-1β/IL-6/IL-17A) promote pathogenic M1/M2a macrophage polarization via STAT6, NF-κB and NLRP3 pathways, aggravating inflammatory responses. Anti-inflammatory ILs (IL-10, IL-27) induce M2c polarization and restore immune balance through STAT3/STAT1 signaling. Targeted interventions (dupilumab, MCC950, chlorogenic acid) effectively reverse polarization imbalance and alleviate AR symptoms. Clinically, AR patients present disrupted IL ratios, M1/M2 imbalance and impaired nasal mucosal barriers.

Conclusion

IL-mediated macrophage polarization is a core driver of AR inflammation. Targeting these regulatory pathways provides promising precision therapeutic strategies for AR.

Subjects

Author keywords

NLRP3allergic rhinitisinflammationinterleukinmacrophage

Authors and institutions

  • Department of Stomatology, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, 150040, People's Republic of China.
  • Department of Rehabilitation, The Fourth Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, 150036, People's Republic of China.
  • Department of Pediatrics II, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, 150040, People's Republic of China.

Cite

APA

Luan, H., Gao, S., Ma, Y., Yu, Z., & Li, X. (2026). Interleukin-Mediated Macrophage Polarization in Allergic Rhinitis Inflammation: A Systematic Review. Journal of Inflammation Research, Volume 19, 1-19. https://doi.org/10.2147/jir.s607167

Vancouver

Luan H, Gao S, Ma Y, Yu Z, Li X. Interleukin-Mediated Macrophage Polarization in Allergic Rhinitis Inflammation: A Systematic Review. Journal of Inflammation Research. 2026;Volume 19:1-19. doi:10.2147/jir.s607167

BibTeX
@article{Luan2026,
  author = {Luan, Haihuan and Gao, Shouwei and Ma, Yuanyuan and Yu, Zeyu and Li, Xiaonan},
  title = {Interleukin-Mediated Macrophage Polarization in Allergic Rhinitis Inflammation: A Systematic Review},
  journal = {Journal of Inflammation Research},
  year = {2026},
  volume = {Volume 19},
  pages = {1--19},
  doi = {10.2147/jir.s607167}
}
Start for free →